Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolent Health, Inc.EVH · Entity 5492 | Director | June 06, 2024 | June 10, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolent Health, Inc.
Report date June 06, 2024 · Filed June 10, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 48,001 |
Reported balance
After 2024-06-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-06-06 · Grant · Acquired 7,709 · Balance 48,001 F1: Represents restricted stock units granted to Dr. Duffy pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date. F3: Since the date of the reporting person's last ownership report, Dr. Duffy transferred 9,643 shares of Evolent Health, Inc. Class A Common Stock pursuant to a domestic relations order. Dr. Duffy no longer reports as beneficially owned any securities owned by her ex-spouse. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted to Dr. Duffy pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date.
F3: Since the date of the reporting person's last ownership report, Dr. Duffy transferred 9,643 shares of Evolent Health, Inc. Class A Common Stock pursuant to a domestic relations order. Dr. Duffy no longer reports as beneficially owned any securities owned by her ex-spouse.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
VOCERA COMMUNICATIONS, INC.
Report date February 18, 2022 · Filed February 23, 2022
Section 16 reporting ended · disclosed 2022-02-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-02-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-02-18 · Grant · Acquired 54,266 · Balance 117,723 F1: Represents the number of shares that vested under (a) a performance stock unit award granted on June 1, 2020 and (b) a performance stock unit award granted on July 1, 2021. Row 2 · 2022-02-23 · Disposition to issuer · Disposed 117,723 · Balance 0 F2: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 6, 2022, by and among the Issuer, Stryker Corporation ("Stryker") and Voice Merger Sub Corp. ("Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Stryker, effective as of February 23, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the common stock was exchanged into the right to receive $79.25 in cash, without interest and less any applicable withholding taxes, at the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares that vested under (a) a performance stock unit award granted on June 1, 2020 and (b) a performance stock unit award granted on July 1, 2021.
F2: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 6, 2022, by and among the Issuer, Stryker Corporation ("Stryker") and Voice Merger Sub Corp. ("Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Stryker, effective as of February 23, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the common stock was exchanged into the right to receive $79.25 in cash, without interest and less any applicable withholding taxes, at the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 03, 2017 Filed Jul 6, 2017 19:20 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 14,313 | $25.87 | $370,337.42 |
DisclosureSEC source: 0001140361-17-027389 · doc1.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,739 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $25.60 to $26.45 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 20:18 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | GrantCommon Stock | 23,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-023864 · doc1.xml · nonDerivative · entry 2 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,052 F2 · shares: Represents a restricted stock unit award that vests in three equal annual installments commencing on June 1, 2018. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 20:18 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Tax withholdingCommon Stock | 14,027 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-023864 · doc1.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,560 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and withheld by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of shares of restricted stock units. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes. F1 · price: Exempt transaction pursuant to Section 16b-3(e) - Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and withheld by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of shares of restricted stock units. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes. Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 20:36 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Exercise / conversionStock Option (Right to Buy) · Derivative | 29,955 | $0.00 Strike: $12.92 | $0.00 |
DisclosureSEC source: 0001140361-17-012196 · doc1.xml · derivative · entry 4 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,427 Underlying: Common Stock · 29,955 shares Expires 2024-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The stock option vests as to 1/48th of the total number of shares in equal monthly installments commencing on July 1, 2014. Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 20:36 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 29,955 | $23.01 | $689,234.60 |
DisclosureSEC source: 0001140361-17-012196 · doc1.xml · nonDerivative · entry 2 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,587 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $23.00 to $23.07 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 20:36 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Exercise / conversionCommon Stock | 29,955 | $12.92 | $387,018.60 |
DisclosureSEC source: 0001140361-17-012196 · doc1.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 20:34 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 12,362 | $20.67 | $255,464.44 |
DisclosureSEC source: 0001140361-17-010650 · doc1.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,587 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $20.50 to $20.81 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.